Don't invest unless you're prepared to lose all the money you invest. This is a high risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more
|
|
|
|
|
|
|
Digital care can help millions of people where traditional care falls short, but health providers face major barriers in buying and rolling out proven health tools. Ripple Scale is building a whole new way for digital care to reach people at scale. By using shared infrastructure, the platform enables multiple evidence-based apps to deploy through a single super app. One contract. One tech stack. One patient experience.
Sign up for priority access and be among the first to learn more when the campaign goes live 👇
|
|
🌎 THE OPPORTUNITY
Healthcare providers face an impossible bottleneck just as the global demand for digital care experiences significant growth.
-
Growing Market Demand: The global mobile health market is forecast to reach £64bn* by 2030, as health systems around the world rapidly expand digital care for prevention, recovery, and condition management.
-
Systemic Pressures: Healthcare providers worldwide, including the NHS, face rising costs and workforce shortages.
-
The Problem: Evidence-based health apps can improve people’s health while reducing pressure on services, but each app still has to be reviewed, procured, integrated, and rolled out separately. Doing this hundreds of times is cumbersome for healthcare providers.
*Based on the current exchange rate.
|
|
💡 WHY RIPPLE SCALE?
Ripple Scale solves the deployment bottleneck by consolidating multiple apps into a single, proven infrastructure.
-
One Unified Experience: Ripple Scale changes the roll-out process by helping experts create, evidence, and publish apps through shared infrastructure, so multiple apps can be deployed through one super app.
-
Proven Tech: The model is powered by Cogniss, a mature no-code infrastructure with AI-powered tech, healthcare-grade security, and simplified compliance, with 50+ quality apps already built and 60+ more currently in production.
-
Real Momentum & Proven Team: Led by senior digital health leaders with international experience in scaling adoption, bringing established relationships across healthcare systems, innovation networks, and global health ecosystems.
|
|
|
|
|
Investing involves risks, including the risk of partial or entire loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. Your investment is not covered by a deposit guarantee scheme or by an investor compensation and scheme. Please read the Risk Warnings before investing. Investments should only be made by investors who understand these risks. Tax treatment depends on individual circumstances and is subject to change in future. Republic Europe does not make investment recommendations to you and any investment decision should be made on the basis of the full campaign. No communications from Republic Europe, through email or any other medium, should be construed as an investment recommendation.
|
|
|
This financial promotion and marketing communication has been approved by Seedrs Limited, authorised and regulated by the Financial Conduct Authority and Seedrs Europe Limited regulated by the Central Bank of Ireland both trading as Republic Europe, on 3 June 2026.
© Seedrs Limited 2026. All rights reserved. Republic Europe is a registered European Community trademark (No. 008771537), registered United Kingdom trademark (No. UK00908771537) and registered United States service mark (No. 85423072). Seedrs Europe Limited is a private company limited by shares registered in Ireland (No. 699574), with registered office at 42, Pearse Street, Dublin 2, D02 YX88, Ireland. Seedrs Limited is a limited company registered in England and Wales (No. 06848016), with registered office at Cubo Soho, Ilona Rose House, Manette Street, London W1D 4AL, United Kingdom, VAT No. GB 208 3065 32.
europe.republic.com is a website owned and operated by Seedrs Europe Limited and/or Seedrs Limited (each trading as Republic Europe).
This message and any attachments are confidential, and may be protected by legal privilege. Nothing in this message shall be considered an offer to sell, or a solicitation of an offer to buy, any security to any person in any jurisdiction to whom or in which such offer, solicitation or sale is unlawful. Republic Europe does not provide legal, financial or tax advice of any kind, and nothing in this email constitutes such advice. If you have any questions with respect to legal, financial or tax matters relevant to your interactions with Republic Europe or its affiliates, you should consult a professional adviser.
Don't want to receive any Featured Campaign Updates? Unsubscribe here. To manage your Republic Europe marketing communications please visit your preferences centre.
|
|
|
|
